Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

3 Healthcare Stocks Insiders Are Buying

Healthcare stocks

Healthcare is a big business and one of few guaranteed to grow. The sector is expected to grow at a 10% CAGR for the next 2 years, at least with the longer-term outlook in the high-single-digits, and that will be spread across verticals and market cap. Today we’re looking at 3 stocks the insiders are buying and have the support of the analyst. 

Beyond Air Is The Most Bought By Insiders 

Ranking the stocks by insider activity, Beyond Air (NASDAQ: XAIR) scores #1. This stock has 7 insiders buying who’ve made at least 11 purchases recently and a string of them since the middle of 2022. Several directors make purchases, the CEO and COO and have total holdings up to about 14% of the company. This is on top of a 19% institutional ownership that has been growing over the past year. 

The analyst sentiment in this stock is exciting, but take that with a grain of salt. The analysts rate the stock a sold Buy with a price target more than 200% above the recent action, but the most recent commentary is about a year old. Beyond Air is a med-tech company focused on respiratory treatments. Its products include a line of respirators built to serve various specific functions, including nitric oxide generation from ambient air. The company is still in the pre-revenue phase but is expected to begin generating income this quarter. The results will vary widely from the analysts' consensus; the outlook for future sales and profitability will drive the market higher or not. 

Precigen Is A Penny Stock With A $10 Target 

Precigen (NASDAQ: PGEN) doesn’t have as many insiders buying, but it has enough to keep the market interested, and the analyst's support is robust. The 4 insiders buying have each made a single purchase that brought the total insider holding to nearly 45%, and the analysts are also buying. The analysts have this stock pegged at a firm Buy, and its ratings are current; less than a month old. The consensus price target is the exciting bit, it’s about 910% above the current action, and even the low price target of $6 assumes a high triple-digit upside.

Precigen is a biotechnology company operating in 3 segments; Biopharmaceuticals, Exemplar and Trans Ova. The Biopharmaceutical segment researches and develops synthetic treatments for various diseases, including gene therapies. The Exemplar segment offers research tools, and the Trans Ova is engaged in bovine reproduction technologies. 

Centene For Blue Chip Stability 

Centene (NYSE: CNC) is a blue-chip operator providing various services for the government. It operates in 4 segments: Medicaid, Medicare, Commercial and Other. It is expected to post industry-beating results this year, and the insiders are buying it. The company has 4 insiders buying, although total holdings are small at less than 0.5%. 

A high 94% institutional interest offsets the low insider ownership, and the institutions also buy. The institutional activity made a noteworthy spike in Q1 2023 which may indicate a high conviction for outperformance this year. The analysts are another bullish force in the market, rating the stock a Moderate Buy with a price target about 40% above the current action. 

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.